Entero Healthcare Solutions Limited (NSE:ENTERO)

Market Cap	61.30B +10.5%
Revenue (ttm)	71.28B +31.9%
Net Income	1.25B +22.3%
EPS	28.78 +22.4%
Shares Out	43.52M
PE Ratio	48.94
Forward PE	32.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,397
Open	1,388.50
Previous Close	1,386.80
Day's Range	1,388.50 - 1,416.90
52-Week Range	944.00 - 1,467.80
Beta	-0.61
Analysts	Strong Buy
Price Target	1,614.00 (+14.6%)
Earnings Date	Aug 7, 2026

About NSE:ENTERO

Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products in India. The company offers a range of pharmaceuticals and other healthcare products to retail pharmacies and healthcare practitioners; and healthcare products, including pharmaceutical and nutraceutical products and vaccines; medical devices, such as orthopaedic implants and coronary stents; and hospital consumables comprising examination and surgical gloves, syringes, needles, and sutures to hospitals and clinics. It also provides private label...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2018
• Employees: 4,671
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ENTERO

Financial Performance

In fiscal year 2026, NSE:ENTERO's revenue was 65.91 billion, an increase of 29.35% compared to the previous year's 50.96 billion. Earnings were 1.15 billion, an increase of 21.33%.

Analyst Summary

According to 4 analysts, the average rating for ENTERO stock is "Strong Buy." The 12-month stock price target is ₹1,614, which is an increase of 14.60% from the latest price.

Price Target

₹1,614

(14.60% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 20, 2026

Data Sources Report a data error